请使用支持JavaScript的浏览器! Medchemexpress/INT-747(Synonyms: Obeticholic acid; 6-ECDCA; 6-Ethylchenodeoxycholic acid)/HY-12222/10mg_蚂蚁淘,【正品极速】生物医学科研用品轻松购|ebiomall 蚂蚁淘商城
商品信息
联系客服
Medchemexpress/INT-747(Synonyms: Obeticholic acid; 6-ECDCA; 6-Ethylchenodeoxycholic acid)/HY-12222/10mg
郑重提醒:
无质量问题不接受退换货,下单前请仔细核对信息。
下单后请及时联系客服核对商品价格,订单生效后再付款。
Medchemexpress/INT-747(Synonyms: Obeticholic acid; 6-ECDCA; 6-Ethylchenodeoxycholic acid)/HY-12222/10mg
美元价:
(友情提示:该价格仅为参考,欢迎联系客服询价!)
数    量:
免费咨询热线
4000-520-616
INT-747isapotentandselectiveFXRagoNIST(EC50=99nM)endowedwithanticholestaticactivity.
Description

INT-747isapotentandselectiveFXRagonist(EC50=99nM)endowedwithanticholestaticactivity.

IC50&Target

EC50:99nM(FXR)

InVitro

6-ECDCAincreasestheexpressionofFXR-regulatedgenesinrathepatocytes[1].INT-747reducesexpressionofliverJNK-1andJNK-2[2].INT-747(256μg/mL)showscompleteinhibitionofbacterialgrowthinallstrainstested.IntestinalpermeABIlityremainsunaffectedafterINT-747-additiontoanIFN-γ-exposedintestinalepitheliumofCaco-2cells[3].

InVivo

6-ECDCA(10mg/kg/day)completelyrevertedcholestasisinducedbyE217α.Administrationof6-ECDCApartiallypreventstheimpairmentintotalbileacidoutputcausedbyE217αbyincreasingtherelativeabundanceofβ-MCAandTCDCAandTDCA[1].INT-747(10mg/kg)andHSincreasesthepulmonarycongestionintheanimals.INT-747doesnotimproverenalpathologyintheHS-fedanimals[2].INT-747(5mg/kg)significantlyincreasessurvivalinBDLrats.INT-747-treatedBDLratsexhibitsasignificantselectiveilealincreaseinexpressionofpore-closingclaudin-1.IlealexpressionofZO-1issignificantlyup-regulatedinINT-747-treatedBDLrats[3].

ClinicalTrial
ViewMoreCollapse
References
  • [1].FiorucciS,etal.Protectiveeffectsof6-ethylchenodeoxycholicacid,afarnesoidXreceptorligand,inestrogen-inducedcholestasis.JPharmacolExpTher.2005May;313(2):604-12.

    [2].GhebremariamYT,etal.FXRagonistINT-747upregulatesDDAHexpressionandenhancesinsulinsensitivityinhigh-saltfedDahlrats.PLoSOne.2013Apr4;8(4):e60653.

    [3].VerbekeL,etal.TheFXRAgonistObeticholicAcidPreventsGutBarrierDysfunctionandBacterialTranslocationinCholestaticRats.AmJPathol.2015Feb;185(2):409-19.

PreparingStockSolutions
ConcentrationVolumeMass1mg5mg10mg
1mM2.3774mL11.8869mL23.7739mL
5mM0.4755mL2.3774mL4.7548mL
10mM0.2377mL1.1887mL2.3774mL
Pleaserefertothesolubilityinformationtoselecttheappropriatesolvent.
AnimalAdministration
[2]

INT-747isformulatedin1%methylcelluloseindistilledwater.

Initially,allanimals(at6-weeksage)areplacedonastandardrodentdietforaweek.Baselinebloodandurinesamplesarecollectedandbasalbloodpressure(BP)ismeasuredpriortogroupingtheanimals.Subsequently,theanimalsarerandomizedintolow(LS;n=9)orhighsalt(HS)dietgroups.HypertensionisinducedintheHSgroupbydailyhigh-saltdietfeedingandthegroupissubdividedtoreceiveoneoftwodosesofINT-747:lowdose(10mg/kg/day;n=15)orhighdose(30mg/kg/day;n=15)in1%methylcellulose;orvehicle(1%methylcelluloseindistilledwater;n=15)orallyeverydayfor6weeks.Inparallel,theLSgroupalsoreceive1%methylcellulose.BPismeasuredweeklyforthedurationofthestudyasdescribedbelow.MCEhasnotindependentlyconfirmedtheaccuracyofthesemethods.Theyareforreferenceonly.

References
  • [1].FiorucciS,etal.Protectiveeffectsof6-ethylchenodeoxycholicacid,afarnesoidXreceptorligand,inestrogen-inducedcholestasis.JPharmacolExpTher.2005May;313(2):604-12.

    [2].GhebremariamYT,etal.FXRagonistINT-747upregulatesDDAHexpressionandenhancesinsulinsensitivityinhigh-saltfedDahlrats.PLoSOne.2013Apr4;8(4):e60653.

    [3].VerbekeL,etal.TheFXRAgonistObeticholicAcidPreventsGutBarrierDysfunctionandBacterialTranslocationinCholestaticRats.AmJPathol.2015Feb;185(2):409-19.

MolecularWeight

420.63

Formula

C₂₆H₄₄O₄

CASNo.

459789-99-2

Storage
Powder-20°C3years
 4°C2years
Insolvent-80°C6months
 -20°C1month
Shipping

RoomtemperatureincontinentalUS;mayvaryelsewhere

Solvent&Solubility

DMSO:≥33mg/mL

*"<1 mg/ml"="" means="" slightly="" soluble="" or="" insoluble.="" "≥"="" means="" soluble,="" but="" saturation="">

Purity:>98.0%